FDA Approved: EPLERENONE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s supplemental application for eplerenone (ANDA 214663), authorizing changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• eplerenone (eplerenone)

Snippet

SUPPL AP for EPLERENONE (EPLERENONE)